Prospective Health Assessment of Cataract Patients' Ocular Surface
Cataract and Dry Eye The PHACO Study (Prospective Health Assessment of Cataract Patients' Ocular Surface)
1 other identifier
observational
200
1 country
1
Brief Summary
This study will determine the incidence and severity of dry eye in patients undergoing cataract surgery as determined by grade on the International Task Force (ITF) scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 13, 2009
CompletedFirst Posted
Study publicly available on registry
November 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedFebruary 1, 2011
January 1, 2011
1.3 years
July 13, 2009
January 31, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of dry eye as evaluated by grade on ITF (International Task Force) level.
One study visit
Secondary Outcomes (1)
TBUT (tear break-up time), OSDI (Ocular surface disease index), corneal staining with fluorescein, conjunctival staining with lissamine, Schirmer's, and a patient questionnaire. These are all standard operations of care.
One study visit
Study Arms (1)
Severity of dry eye in patients undergoing cataract surgery
Eligibility Criteria
Primary care clinic.
You may qualify if:
- Patients should be at least 55 years old.
- Patients must be scheduled to undergo cataract surgery.
You may not qualify if:
- No previous intraocular surgery in the previous 3 months in either eye.
- No previous Corneal laser vision correction in either eye within the last one year.
- No previous lid surgery within the past 3 months.
- Patients may not have used topical antibiotics, topical NSAIDs or topical steroid in either eye in the past month.
- Patients are not eligible if they have recently been started on Restasis solely as a perioperative treatment regimen.
- Patients presently using Restasis in either eye will not undergo any of the study testing but a questionnaire should be completed for these patients regarding use of these medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Center for Excellence in Eye Care
Miami, Florida, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Trattler, MD
The Center for Excellence in Eye Care
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 13, 2009
First Posted
November 19, 2009
Study Start
June 1, 2009
Primary Completion
September 1, 2010
Study Completion
September 1, 2010
Last Updated
February 1, 2011
Record last verified: 2011-01